Pulmonary Embolism Archives - Carey Danis & Lowe

Federal Trade Commission Concludes Investigation into Bayer Pharmaceuticals and Yasmin Patent Litigation

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published October 12, 2012 by LawsuitInformation.org

Federal Trade Commission Concludes Investigation into Bayer Pharmaceuticals and Yasmin Patent LitigationIn recent news regarding Bayer Pharmaceuticals, the German pharmaceutical giant responsible for the manufacture of Yaz and Yasmin, the Federal Trade Commission made the decision to terminate its investigation into a patent settlement between Bayer and Teva Pharmaceuticals.

In 2008, the two pharmaceutical companies reached an agreement in regards to Bayer’s claim that Barr Laboratories, which was ultimately purchased by Teva Pharmaceuticals, overstepped the boundaries of intellectual property protecting Bayer’s Yasmin patent. The 2008 settlement drew the attention of the FTC, and led to a four year investigation into the settlement agreement’s possible antitrust violations.

Though the investigation has ended, Bayer Pharmaceuticals is still tied up in a Multi-District Litigation in the Southern District of Illinois regarding a large number of Yaz and Yasmin lawsuits.

The U.S. Food and Drug Administration released data last October 2011 regarding a Yaz and Yasmin study they conducted in order to determine the drug’s link to the development of blood clots in women. The FDA’s research indicated that among the approximately 800,000 women, they recorded an increased risk of suffering from the development of a blood clot.

It is believed that the chemical drospirenone, which is present in both Yaz and Yasmin, causes health complications in women. The presence of drospirenone in the body elevates levels of potassium, and thus, puts women at a higher risk of developing a blood clot.

Yaz and Yasmin side effects include:

  • Blood clots
  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism

Deep Vein Thrombosis is a serious health condition in which a blood clot forms in a deep vein, most often in a vein in the leg. DVT has been known to cause extreme pain in the location of the blood clot. The danger of DVT is the blood clot migrating to the lungs or brain, causing a more serious and life-threatening condition.

Pulmonary Embolism occurs when a blood clot enters an artery in the lungs, thus obstructing the normal flow of blood to the lungs, and resulting in a lack of oxygen delivery throughout the entire body.

If you or a loved one has suffered from a blood clot caused by the use of either Yaz or Yasmin, you may be eligible to receive compensation for your suffering. To file a Yaz lawsuit or a Yasmin lawsuit, contact our experienced pharmaceutical litigation lawyers at Carey Danis & Lowe.

Yaz/Yasmin DVT & Pulmonary Embolism Settlements Progressing

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published July 10, 2012 by LawsuintInformation

Yaz Deep Vein Thrombosis & Pulmonary Embolism Settlements ProgressingAs a Yaz Pulmonary Embolism, Deep Vein Thrombosis Attorney I have written extensively about the risks inherent in birth control pills containing Drospirenone.

According to status report held on June 22, in the U.S. District Court for the Southern District of Illinois, Bayer has reached agreements with about 33 different law firms to resolve at least 1,444 Yaz Deep Vein Thrombosis, Stroke and Pulmonary Embolism claims.

According to Bloomberg News, as of late April, Bayer faced 11,900 lawsuits over Yaz and its sister drug Yasmin in the U.S. with about 14,000 plaintiffs. Experts predict that the company may have to pay up to $2.65 billion to settle all of the pending cases.

Bayer, the manufacturer of Yaz, Yasmin and Ocella, began settlement negotiations earlier in January, with women who claimed venous thromboembolism blood clot-related personal injuries allegedly caused by side effects of these oral contraceptive birth control pills.

Yaz Federal MDL

All federal cases have been centralized for pretrial proceedings in the U.S. District Court for the Southern District of Illinois. These lawsuits are consolidated as part of an MDL, or multidistrict litigation.

No Venous Thrombotic Bellwether Trials

According to the hearing conference minutes, the judge overseeing the MDL litigation, opined that there are not going to be any bellwether cases involving venous thrombotic injuries. The reason apparently was because the settlement process is continuing to work to resolve the remaining injury cases.

Bayer is only settling Yaz lawsuits involving a pulmonary embolism or deep vein thrombosis injury at this time. A deep vein thrombosis (DVT) is a blood clot that occurs in the deep veins of the legs or pelvis. A pulmonary embolism occurs when the leg blood clot breaks off, travels through the blood stream and becomes lodged in the lung.